-PTI In view of unsatisfactory progress by schools in meeting the March 31 RTE deadline, an education forum today indicated moving to court for ensuring legal entitlement under the Act and demanded Prime Minister Manmohan Singh's intervention in the matter. RTE Forum, a platform of national education networks and teachers, among others said they would demand that the Prime Minister convenes a meeting of chief ministers to ensure efficient implementation of...
More »SEARCH RESULT
Total Matching Records found : 4372
RIL, Adani Power got undue favours from Gujarat PSUs
-The Business Standard CAG says GSPL did not safeguard its own interest leading to passing on of undue benefit of Rs 52 cr to RIL In what could add more teeth to the opposition party's allegations against the Narendra Modi-led Gujarat government, the Comptroller and Auditor General of India (CAG)'s latest report has brought out fresh details of undue favour by state public sector undertakings (PSUs) to Reliance Industries Limited (RIL) and...
More »Delhi govt favoured private discoms: CAG
-The Indian Express Report finds govt did not recover dues of Rs 750 cr from distributors. At a time when the opposition BJP plans to intensify protests against power tariff in Delhi, the Comptroller and Auditor General (CAG) of India's report for the 2011-12 fiscal has slammed the Delhi government for not recovering dues to the tune of Rs 750 crore from private distribution companies. The report, tabled on Tuesday in the Delhi...
More »CAG raps Bihar govt for 'fiscal indiscipline'
-The Times of India PATNA: The Bihar government, which keeps crying for more central assistance, could not spend Rs 1472.61 crore in 2012 and surrendered 100 per cent funds in 192 schemes, depriving the beneficiaries of the benefits, according to the CAG report for 2011-12 presented in state assembly on Tuesday. Central funds for several schemes also remained unutilized, it said. The CAG also regretted the lack of objective planning in utilization...
More »Glivec lesson for pharma: Patented drugs must be priced smartly-Kiran Mazumdar Shaw
-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...
More »
